Omadacycline powder for research procured from unauthorized commercial vendors may be impure and/or unstable.
作者信息
Serio Alisa W, Deck Daniel H, Wright Kelly, Manion Kristen
机构信息
Paratek Pharmaceuticals, Inc, King of Prussia, Pennsylvania, USA.
出版信息
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0063824. doi: 10.1128/aac.00638-24. Epub 2024 Jun 18.
Abstract
摘要
相似文献
1
Omadacycline powder for research procured from unauthorized commercial vendors may be impure and/or unstable.
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0063824. doi: 10.1128/aac.00638-24. Epub 2024 Jun 18.
2
Comparative Activity of Omadacycline against Dog and Cat Bite Wound Isolates.
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02551-17. Print 2018 Apr.
3
Activity of Omadacycline against .
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01907-18. Print 2019 Feb.
4
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
Diagn Microbiol Infect Dis. 2020 Jul;97(3):115054. doi: 10.1016/j.diagmicrobio.2020.115054. Epub 2020 Apr 2.
5
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
Antimicrob Agents Chemother. 2014;58(3):1279-83. doi: 10.1128/AAC.01066-13. Epub 2013 Sep 16.
6
Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants.
Diagn Microbiol Infect Dis. 2019 May;94(1):78-80. doi: 10.1016/j.diagmicrobio.2018.11.010. Epub 2018 Nov 29.
7
Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in Stockholm, Sweden.
Microbiol Spectr. 2021 Oct 31;9(2):e0144021. doi: 10.1128/Spectrum.01440-21. Epub 2021 Oct 6.
8
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Drugs. 2020 Feb;80(3):285-313. doi: 10.1007/s40265-020-01257-4.
9
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
Diagn Microbiol Infect Dis. 2018 Feb;90(2):143-147. doi: 10.1016/j.diagmicrobio.2017.10.010. Epub 2017 Oct 19.
10
Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of .
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00470-19. Print 2019 Jun.
本文引用的文献
1
Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity .
Microbiol Spectr. 2023 Jun 15;11(3):e0071823. doi: 10.1128/spectrum.00718-23. Epub 2023 May 4.
2
Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.
Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0145922. doi: 10.1128/aac.01459-22. Epub 2023 Jan 23.
3
Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.
Microbiol Spectr. 2023 Feb 14;11(1):e0323822. doi: 10.1128/spectrum.03238-22. Epub 2022 Dec 8.
4
Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.
PLoS Biol. 2022 Sep 28;20(9):e3001808. doi: 10.1371/journal.pbio.3001808. eCollection 2022 Sep.
5
Omadacycline Efficacy against Enterococcus faecalis Isolated in China: Activity, Heteroresistance, and Resistance Mechanisms.
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.02097-19.
6
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01603-19.
7
Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of .
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00470-19. Print 2019 Jun.
Zotero 插件